RxDoctor Payments Data

John Meyers, MD

Obstetrics & Gynecology · Daytona Beach, FLNPI 1366448805

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,400 of the $11,880 with a category attached, or 87.5%. Mimedx Group, Inc. accounts for 87.5% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $7,093, more than ten times the $265 reported in 2019. Among obstetrics & gynecology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,880in general payments, 2019–2025

Across 100 payments — averaging $118.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mimedx Group, Inc.$10K
  • Hologic Sales And Service, LLC$247
  • AbbVie$228
  • Exeltis, USA Inc.$148
  • Amgen$132
  • Pfizer$95
  • plus $629 from 17 others

What the payments were for

  • Consulting fees$10,40088%
  • Food & beverage$1,48012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,880 in reported general payments places this provider in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida →

Medicare billing

Part B allowed, 2024
$25,503
Medicare patients
175
Services billed
397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated12$5,109
Estradiol126$4,150
Medroxyprogesterone Acetate34$506
Megestrol Acetate12$286
Temazepam12$148
Triamcinolone Acetonide12$76

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$95$5,10912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.

Other obstetrics & gynecology in Daytona Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →